South Korea Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)...

toegevoegd een audio Other

2025-08-08 11:45:56 - Translate

South Korea Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market Growth Fueled by Innovation in Hematologic Oncology

The South Korea blastic plasmacytoid dendritic cell neoplasm (BPDCN) market, valued at USD 42.88 million in 2024, is forecast to expand at a compound annual growth rate (CAGR) of 7.20% between 2025 and 2034, reaching an estimated USD 85.78 million by 2034. Growth will be propelled by improved disease awareness, advancements in targeted therapies, wider diagnostic...

0 Reacties 0 aandelen 2K Views 0 voorbeeld